Melanoma: Epidemiology, risk factors, pathogenesis, diagnosis and classification

In Vivo

Volumn 28, Issue 6, 2014, Pages 1005-1012

  Rastrelli, Marco ^a   Tropea, Saveria ^a   Rossi, Carlo Riccardo ^b   Alaibac, Mauro ^b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Classification; Dermoscopy; Diagnosis; Epidemiology; Melanoma; Pathogenesis; Reflect confocal microscopy; Review; Risk factors

Indexed keywords

PSORALEN;

ACRAL LENTIGINOUS MELANOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CONFOCAL MICROSCOPY; CUTANEOUS MELANOMA; ENVIRONMENTAL EXPOSURE; EPILUMINESCENCE MICROSCOPY; GENETIC SUSCEPTIBILITY; HUMAN; MALIGNANT LENTIGO; MEDICAL DECISION MAKING; MELANOCYTIC NEVUS; MELANOMA; META ANALYSIS (TOPIC); PHOTOCHEMOTHERAPY; REVIEW; SELF EXAMINATION; SEX; SKIN EXAMINATION; SUN EXPOSURE; ULTRAVIOLET A RADIATION; ULTRAVIOLET RADIATION; RISK FACTOR;

HUMANS; MELANOMA; RISK FACTORS;

EID: 84918538132     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. MacKie RM, Hauschild A and Eggermont AM: Epidemiology of invasive cutaneous melanoma. Ann Oncol 20: 1-7, 2009.
2. Duncan LM: The classification of cutaneous melanoma. Hematol Oncol Clin North Am 23: 501-513, 2009.
3. Meyle KD and Guldberg P: Genetic risk factors for melanoma. Hum Genet 4: 499-510, 2009.
4. Caini S, Gandini S, Sera F, Raimondi S, Fargnoli MC, Boniol M and Armstrong BK: Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinicopathological variant. Eur J Cancer 17: 3054-3063, 2009.
5. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET and Melanoma Study Group of the Mayo Clinic Cancer Center: Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 3: 364-380, 2007.
6. Rigel DS: Epidemiology of melanoma. Semin Cutan Med Surg 4: 204-209, 2010.
7. Lasithiotakis K, Leiter U, KrügerMacKie RM, Hauschild A and Eggermont AM: Epidemiology of invasive cutaneous melanoma. Ann Oncol 20(Suppl 6): vi1-7, 2010.
8. Krasagakis S, Tosca A and Garbe C: Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg). Br J Dermatol 6: 1123-1127, 2006.
9. Sera F,Gandini S Cattaruzza MS, Pasquini P, Picconi O, Boyle P and Melchi CF: Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41: 45-60, 2015.
10. Elwood JM and Jopson J: Melanoma and sun exposure: an overview of published studies. Int J Cancer 73: 198-203, 1997.
11. Elwood JM, Gallagher RP, Worth AJ, Wood WS and Pearson JC: Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 78: 37-44, 1987.
12. International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer: The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 120: 1116-1122, 2007.
13. Stern RS: The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 44: 755-761, 2001.
14. Bevona C, Goggins W, Quinn T, Fullerton J and Tsao: Cutaneous melanomas associated with nevi. Arch Dermatol 139: 1620-1624, 2003.
15. Holly EA, Kelly JW, Shpall SN and Chiu SH: Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17: 459-468, 1987.
16. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, Noe MC, Diconstanzo MP and Bonerandi JJ: Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 66: 387-395, 1990.
17. Halpern AC, Guerry D 4th, Elder DE, Clark WH Jr, Synnestvedt M, Norman S and Ayerle R: Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol 127: 995-999, 1991.
18. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P and Melchi CF: Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41: 28-44, 2005.
19. Watt AJ, Kotsis SV and Chung KC: Risk of melanoma arising in large congenital melanocytic nevi: a systematic review. Plast Reconstr Surg 113: 1968-1974, 2004.
20. Tannous ZS, Mihm MC Jr., Sober AJ and Duncan LM: Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol 52: 197-203, 2005.
21. Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, Guerry D 4th and Clark WH Jr: Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA 277: 1439-1444, 1997.
22. Purdue MP, From L and Armstrong BK: Genes, Environment, and Melanoma Study Group. Etiologic and other factors predicting nevus associated cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 14: 2015-2022, 2005.
23. Tsao H and Niendorf K: Genetic testing in hereditary melanoma. J Am Acad Dermatol 51: 803-808, 2004.
24. Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J and Bergman W: Multiple primary melanomas. J Am Acad Dermatol 44: 22-27, 2001.
25. Veierod MB, Weiderpass E, Thörn M, Hansson J, Lund E, Armstrong B and Adami HO: A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 95: 1530-1538, 2003.
26. Titus-Ernstoff L, Perry AE, Spencer SK, Gibson JJ, Cole BF and Ernstoff MS: Pigmentary characteristics and moles in relation to melanoma risk. Int J Cancer 116: 144-149, 2005.
27. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, Boyle P and Melchi CF: Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41: 204-2059, 2005.
28. Rigel DS, Russak J and Friedman R: The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin 5: 301-316, 2010.
29. Montella A, Gavin A, Middleton R, Autier P and Boniol M: Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. Eur J Cancer 45: 2360-2366, 2009.
30. Bevona C and Sober AJ: Melanoma incidence trends. Dermatol Clin 20: 589-595, 2002.
31. Robinson JK and Turrisi R: Skills training to learn discrimination of ABCDE criteria by those at risk of developing melanoma. Arch Dermatol 142: 447-452, 2006.
32. Friedman RJ, Rigel DS and Kopf AW: Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin 35: 130-151, 1985.
33. Branstrom R, Hedblad MA, Krakau I and Ullen H: Laypersons' perceptual discrimination of pigmented skin lesions. J Am Acad Dermatol 46: 667-673, 2002.
34. Rigel DS and Friedman RJ: The rationale of the ABCDs of early melanoma. J Am Acad Dermatol 29: 1060-1061, 1993.
35. Thomas L, Tranchand P, Berard F, Secchi T, Colin C and Moulin G: Semiological value of ABCDE criteria in the diagnosis is of cutaneous pigmented tumors. Dermatology 197: 11-17, 1998.
36. MacKie RM: Clinical recognition of early invasive malignant melanoma. BMJ 301: 1005-1006, 1990.
37. Grob JJ and Bonerandi JJ: The "ugly duckling" sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol 134: 103-104, 1998.
38. Scope A, Dusza SW, Halpern AC, Rabinovitz H, Braun RP, Zalaudek I, Argenziano G and Marghoob AA: The "ugly duckling" sign: agreement between observers. Arch Dermatol 144: 58-64, 2008.
39. Neila J and Soyer HP: Key points in dermoscopy for diagnosis of melanomas, including difficult to diagnose melanomas, on the trunk and extremities. J Dermatol 38: 3-9, 2011.
40. Hofmann-Wellenhof R, Wurm EM, Ahlgrimm-Siess V, Richtig E, Koller S, Smolle J and Gerger A: Reflectance confocal microscopy - state-of-art and research overview. Semin Cutan Med Surg 28: 172-179, 2009.
41. Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, Binder M, Cerroni L, De Rosa G, Ferrara G, Hofmann-Wellenhof R, Landthaler M, Menzies SW, Pehamberger H, Piccolo D, Rabinovitz HS, Schiffner R, Staibano S, Stolz W, Bartenjev I, Blum A, Braun R, Cabo H, Carli P, De Giorgi V, Fleming MG, Grichnik JM, Grin CM, Halpern AC, Johr R, Katz B, Kenet RO, Kittler H, Kreusch J, Malvehy J, Mazzocchetti G, Oliviero M, Ozdemir F, Peris K, Perotti R, Perusquia A, Pizzichetta MA, Puig S, Rao B, Rubegni P, Saida T, Scalvenzi M, Seidenari S, Stanganelli I, Tanaka M, Westerhoff K, Wolf IH, Braun-Falco O, Kerl H, Nishikawa T, Wolff K and Kopf AW: Dermoscopy of pigmented skin lesions: results of a consensus meeting via the internet. J Am Acad Dermatol 5: 679-693, 2003.